Go Pro
→ Your book is inside (From Profits Run) (Ad)tc pixel Free CELUW Stock Alerts

Celularity (CELUW) Competitors

Celularity logo
$0.0021 0.00 (-40.58%)
As of 07/13/2026 03:45 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

CELUW vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

Should you buy Celularity stock or one of its competitors? MarketBeat compares Celularity with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Celularity include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does Celularity compare to Ainos?

Celularity (NASDAQ:CELUW) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, risk, profitability, earnings, valuation and dividends.

In the previous week, Ainos had 1 more articles in the media than Celularity. MarketBeat recorded 2 mentions for Ainos and 1 mentions for Celularity. Celularity's average media sentiment score of 1.89 beat Ainos' score of 1.74 indicating that Celularity is being referred to more favorably in the media.

Company Overall Sentiment
Celularity Very Positive
Ainos Very Positive

Company Net Margins Return on Equity Return on Assets
CelularityN/A N/A N/A
Ainos N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Celularity$26.55MN/AN/AN/AN/A
Ainos$18.11KN/AN/AN/AN/A

Summary

Celularity beats Ainos on 2 of the 3 factors compared between the two stocks.

How does Celularity compare to Alvotech?

Celularity (NASDAQ:CELUW) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, institutional ownership, valuation, analyst recommendations, risk and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Celularity$26.55MN/AN/AN/AN/A
Alvotech$559.42MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
CelularityN/A N/A N/A
Alvotech N/A N/A N/A

In the previous week, Celularity and Celularity both had 1 articles in the media. Celularity's average media sentiment score of 1.89 equaled Alvotech'saverage media sentiment score.

Company Overall Sentiment
Celularity Very Positive
Alvotech Very Positive

Summary

Alvotech beats Celularity on 1 of the 1 factors compared between the two stocks.

How does Celularity compare to Aravive?

Celularity (NASDAQ:CELUW) and Aravive (NASDAQ:ARAV) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, analyst recommendations, valuation, media sentiment, institutional ownership and profitability.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Celularity$26.55MN/AN/AN/AN/A
AraviveN/AN/AN/A-$0.90N/A

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Company Net Margins Return on Equity Return on Assets
CelularityN/A N/A N/A
Aravive N/A N/A N/A

In the previous week, Celularity had 1 more articles in the media than Aravive. MarketBeat recorded 1 mentions for Celularity and 0 mentions for Aravive. Celularity's average media sentiment score of 1.89 beat Aravive's score of 0.00 indicating that Celularity is being referred to more favorably in the media.

Company Overall Sentiment
Celularity Very Positive
Aravive Neutral

Summary

Celularity beats Aravive on 3 of the 5 factors compared between the two stocks.

How does Celularity compare to Atlantic Coastal Acquisition Corp. II?

Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and Celularity (NASDAQ:CELUW) are both pharmaceutical products companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, dividends, risk, profitability and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A
Celularity$26.55MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Atlantic Coastal Acquisition Corp. IIN/A N/A N/A
Celularity N/A N/A N/A

In the previous week, Celularity had 1 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 1 mentions for Celularity and 0 mentions for Atlantic Coastal Acquisition Corp. II. Celularity's average media sentiment score of 1.89 beat Atlantic Coastal Acquisition Corp. II's score of 0.00 indicating that Celularity is being referred to more favorably in the news media.

Company Overall Sentiment
Atlantic Coastal Acquisition Corp. II Neutral
Celularity Very Positive

Summary

Celularity beats Atlantic Coastal Acquisition Corp. II on 3 of the 3 factors compared between the two stocks.

How does Celularity compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and Celularity (NASDAQ:CELUW) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, dividends, risk, earnings, valuation and institutional ownership.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$43.20MN/AN/AN/AN/A
Celularity$26.55MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
Celularity N/A N/A N/A

In the previous week, Biofrontera and Biofrontera both had 1 articles in the media. Celularity's average media sentiment score of 1.89 beat Biofrontera's score of 1.87 indicating that Celularity is being referred to more favorably in the news media.

Company Overall Sentiment
Biofrontera Very Positive
Celularity Very Positive

Summary

Biofrontera and Celularity tied by winning 1 of the 2 factors compared between the two stocks.

Get Celularity News Delivered to You Automatically

Sign up to receive the latest news and ratings for CELUW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CELUW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CELUW vs. The Competition

Export
MetricCelularityBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$510.06M$7.05B$12.61B
Dividend YieldN/A3.90%2.68%8.00%
P/E RatioN/A3.1627.1124.26
Price / SalesN/A6,474.90589.18117.88
Price / CashN/A13.1329.2249.36
Price / BookN/A85.6710.736.29
Net IncomeN/A-$96.07M$3.58B$330.66M
7 Day PerformanceN/A-0.96%-2.11%-1.35%
1 Month PerformanceN/A2.45%3.27%-0.64%
1 Year PerformanceN/A59.98%26.32%19.08%

Celularity Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CELUW
Celularity
N/A$0.00
-40.6%		N/AN/A$0.00$26.55MN/A220
AIMDW
Ainos
N/A$0.13
-13.6%		N/A+23.5%$0.00$18.11KN/A40
ALVOW
Alvotech
N/A$0.20
+17.6%		N/AN/A$0.00$559.42MN/A4
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat		N/AN/A$0.00N/AN/A15

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:CELUW) was last updated on 7/14/2026 by MarketBeat.com Staff.
From Our Partners
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”
In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...
Paradigm Press | Sponsoredtc pixel
Under $1 while the market panics
The new deadline for crypto’s best bill, the Clarity Act, is August 7th. That's the Senate's final session day...
Crypto 101 Media | Sponsoredtc pixel
BSEM Announces Major Corporate Milestone
BioStem Technologies (OTC: BSEM) has publicly filed a Form 10 registration statement with the SEC, advancing i...
Huge Alerts | Sponsoredtc pixel
American’s Biggest Threat Is Here
This feels like one of those ''where were you when Kennedy was shot'' moments. It felt like a moment in time, ...
Goldco Direct, LLC | Sponsoredtc pixel
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
They proved it worked in '76. Then buried it.
In 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...
Behind the Markets | Sponsoredtc pixel